Jim Bender - US Senate 2010
Jim Bender statement on proposed FDA rules regarding breast cancer drug Avastin and its potential limited availability to women
Hollis, NH- “The Food and Drug Administration or any other government agency should not be making the decision as to whether continued treatment with the drug Avastin is worth it. If this medicine extends the life of a mother, a daughter, a sister, and a friend, it most certainly is. The FDA’s job is to look at product safety and effectiveness and their decisions should not be impacted on cost of treatment,” said Jim Bender.
“Anything else sets the stage for a situation that could be dangerous for the health of all Americans. The Federal government is in no position to determine that the life of a woman with breast cancer is not valuable enough.”
“President Obama said that coverage would not change while he is in the White House. This new direction that the FDA is headed is just the tip of the iceberg of what we can expect under government run health care; more and more rationing. If I am elected I will go to Congress and work tirelessly to repeal the health care law and end the attempts by the government to takeover of our lives from cradle to grave,” concluded Bender.